Control group:Placebo administration

A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Phase Ia Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, Pharmacodynamics Profile and Immunogenicity of SGC001 in Healthy Adult Subjects

A Randomized, Double-Blind, Placebo-Controlled, Single Dose escalation Phase Ib Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, Immunogenicity, and Initial efficacy of SGC001 in Patients Scheduled to undergo Percutaneous Coronary Intervention for Anterior ST-segment Elevation Myocardial Infarction